Evidence of focusing the MHC class I immunopeptidome by tapasin
Major Histocompatibility Complex class I (MHC-I) molecules bind and present peptides to cytotoxic T cells, protecting against pathogens and cancer. MHC-I is highly polymorphic and each allotype is promiscuous, and capable of binding a unique and diverse repertoire of peptide ligands. The peptide editing chaperone tapasin optimizes this allotype specific repertoire of peptides, resulting in the selection of high affinity peptides. MHC-I allotypes differ in the extent they engage tapasin. This suggests that tapasin-dependent MHC-I allotypes should present a less diverse repertoire that is enriched in higher-affinity peptides, and which are present in higher abundance, than tapasin independent MHC-I allotypes, which should present a broader repertoire containing peptides with a lower average affinity. Experimental verification of this hypothesis has been confounded by the different peptide binding specificities of MHC-I allotypes. Here, we independently investigated the peptide focusing function of tapasin by introducing a point mutation into a tapasin independent MHC-I allotype that dramatically increased its tapasin dependence without substantially altering its peptide binding specificity. This allowed us to demonstrate ligand focusing by tapasin at both the repertoire level <i>in cellulo</i>, and by using an <i>in vitro</i> system in which tapasin was artificially tethered to MHC-I, at the individual peptide level. We found that tapasin had a greater influence on tapasin dependent MHC-I molecules, and that tapasin modulated peptide selection according to peptide-MHC-I complex stability, disfavoring short-lived peptide-MHC-I complexes. Thus, tapasin dependent MHC-I molecules experience greater tapasin filtering, resulting in less diverse MHC-I immunopeptidomes that are enriched in high affinity peptide-MHC-I complexes.
Authors
- Patricia T. Illing (ORCID: https://orcid.org/0000-0002-3870-0796)
- Rachel Darley
- Andy van Hateren (ORCID: https://orcid.org/0000-0002-3915-0239)
- A.G. Bailey (ORCID: https://orcid.org/0000-0003-0023-8679)
- Tim Elliott (ORCID: https://orcid.org/0000-0003-1097-0222)
- Patrick J. Duriez (ORCID: https://orcid.org/0000-0003-1814-2552)
- Anthony W. Purcell (ORCID: https://orcid.org/0000-0003-0532-8331)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Discovery Institute (US)
- Angkor Hospital for Children (KH)
- Cancer Research UK (GB)
- University of Southampton (GB)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fimmu.2025.1563789
- Citations
- 3
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- Cancer Research UK
- Monash University
- Medical Research Council
- National Health and Medical Research Council